Drug Status in USA : Approved Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Ovarian carcinoma. Breast Cancer. Advanced non-smell cell lung cancer. AIDS related Kaposis sarcoma.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient Hypersensitivity. Pregnancy, lactation and children. concurrent serious uncontrolled infections.
Other Precaution to be observed while taking this medication
Bone marrow suppression during therapy.
What are possible side effects of this medication ?
Bone marrow depression, hypersensitivity reactions, myalgia, chest pain, bradycardia, a stocking-glove sensory neuropathy, mucositis, nausea, vomiting, diarrhoea, alopeia. Tachycardia, rash, hypotension, arthralgia, rarely hepatic necrosis and encephalopathy.
Drug Category/Class
Antineoplastic Agents
Immunosuppressive Agents
Antineoplastic Agents, Phytogenic
Tubulin Modulators
Antineoplastic and Immunomodulating Agents
Taxanes
BSEP
ABCB11 Inhibitors
Combined Inhibitors of CYP3A4 and P-glycoprotein
Cytochrome P-450 CYP2C9 Inhibitors
Cytochrome P-450 CYP2C8 Inhibitors
Cytochrome P-450 CYP2C9 Inducers
Cytochrome P-450 CYP2C8 Inducers
CYP3A4 Inhibitors
Prescribed
Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of meta...